Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) was the recipient of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 156,700 shares, a growth of 2,468.9% from the November 30th total of 6,100 shares. Based on an average daily trading volume, of 745,200 shares, the short-interest ratio is currently 0.2 days.

Q BioMed Price Performance

Shares of QBIO traded down $0.00 during mid-day trading on Wednesday, hitting $0.01. 642,508 shares of the company's stock were exchanged, compared to its average volume of 443,292. Q BioMed has a 52 week low of $0.01 and a 52 week high of $0.58. The company has a 50-day simple moving average of $0.02 and a 200 day simple moving average of $0.03.

Q BioMed (OTCMKTS:QBIO – Get Rating) last issued its earnings results on Thursday, November 3rd. The company reported ($0.03) earnings per share for the quarter. The firm had revenue of $0.03 million during the quarter.

About Q BioMed

Q BioMed Inc, a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain.

See Also

• Get a free copy of the StockNews.com research report on Q BioMed (QBIO)
• The Top Three Stocks Analysts Say To Buy
• Can Dick's Sporting Goods Stock Score Another Win In Q4?
• Yum! Brands Looks Tasty in 2023
• Why Did Immutep Ltd Stock Soar Recently?
• 3 Industrial Stocks to Help Build Your 2023 Watchlist

Receive News & Ratings for Q BioMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Q BioMed and related companies with MarketBeat.com's FREE daily email newsletter.